Madely Health Headlines Commentary for February 10, 2010

Source:

Paxil, Tamoxifen May Be a Risky Combo

Reference:

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

Related articles:

  1. Tamoxifen shown to reduce breast cancer recurrence for women with early stage disease
  2. More information needed about woman’s breast cancer before slamming Ontario Government for not covering breast-cancer drug
  3. Sunday House Call, #327, November 7, 2010
  4. Breast cancer risk from hormone replacement needs perspective when compared to other contributing factors
  5. Preliminary evidence suggests that anti-inflammatory medications may interfere with antidepressant efficacy